about
Parasitic Infections in Hematopoietic Stem Cell TransplantationBlastoschizomyces capitatus infection in patients with leukemia: report of 26 cases[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].[New antifungal drugs. Present and future][In vitro antifungal activity of micafungin].Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patientsFluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methodsProspective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemiaEpidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.Two cases of fungemia due to Candida lusitaniae and a literature review.Effect of statin use on outcomes of adults with candidemia.Multilocus microsatellite analysis of European and African Candida glabrata isolates.Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilutionMulticenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study).Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesAntifungal drug resistance mechanisms.Current diagnostic approaches to invasive candidiasis in critical care settings.Update on invasive mycoses by filamentous fungi in critically ill patients.EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.Jávea consensus guidelines for the treatment of Candida peritonitis and other intra-abdominal fungal infections in non-neutropenic critically ill adult patients.Candidemia in major burns patients.Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.Risk factors, clinical presentation and prognosis of mixed candidaemia: a population-based surveillance in Spain.[Update on invasive candidiasis in non-neutropenic critically ill adult patients].[Current aspects of invasive diseases caused by Candida and other yeast fungi].Patterns of amphotericin B killing kinetics against seven Candida species.Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).Bacterial and fungal contamination risks in human oocyte and embryo cryopreservation: open versus closed vitrification systems.
P50
Q26740380-88E4DA53-57A8-4966-A9F1-FF1FC172F4CAQ28239042-0A91D627-E7C0-43BC-8241-C5764F24E7D8Q31129662-52D76F32-583A-45E3-9F7A-81E9D47DAB63Q31401594-2AE33740-78CC-4F51-B3BA-F2052A9F973FQ33451088-6588E776-247B-47C6-B707-6C9ABA1254B2Q33841485-1F9141B3-A1E5-4B55-8219-AF0D4E2B87F5Q33961413-E6691503-3CAB-491E-ADE7-B28CD88FB100Q34022724-B63D1127-89CD-43F0-B2AC-3154B1214094Q34165039-6B85EA0F-F3A8-4138-BD59-C465FF777C9DQ34694390-86048411-4AEA-4384-86C8-8169AF54ACF5Q35025431-D2038AC1-6FA8-441B-A50F-1C6BBFC22D10Q35946831-B9527954-6EE6-40A6-9905-4AFDE9213679Q36022956-D50BAA9A-1C0D-4024-AB65-AF1C4CF925E8Q36158263-2E9B5986-0054-4D72-AB5B-3E536FF2CB7DQ36308069-4CDA1DF3-4C4F-4F51-9A04-9D27D520A469Q36969672-F38D2E23-C385-4B3D-9FFD-2A0E3DF4BC59Q37098160-C657392B-60F5-48A0-AF9B-F1C8E4CDF3E2Q37124108-C0D0B8E2-0593-41D2-A881-8BB310E82720Q37157546-45BF4754-7977-4CA6-BF8F-6B40F5434CBDQ37463223-88F60311-DF35-4C0F-91F6-3564B9224ABCQ37559821-CC317E8E-86E7-4A90-BACB-0A26EDA4CD5BQ37860559-23070033-0C3B-438D-BB1F-CC461A063AFAQ38898472-72386ACC-6F22-4D65-B4B6-55B557654F31Q39029924-848390BE-5257-4F79-9336-E7606B5B5053Q39092317-D5E73FDE-6807-4DF6-A6B4-EC1103EBD553Q39195902-F1DA532C-E936-45CD-AD5A-01BA9FE0EC18Q39349172-3049C1D8-E455-49DC-B69A-72C3CE31F643Q39956387-B40D395E-F5A5-47E9-8D03-CC999B80E522Q40135487-E35990EC-F725-4ACE-B6F7-ED3B336E1AD4Q40337192-80D77E0B-FD7E-4FC6-9EED-3C85394C360DQ40458611-DB75941B-486B-407F-8C1A-A01EC9E2E474Q40524039-D1C9989E-2FEC-48BA-9329-58BF0E982107Q40569093-49203A52-FE46-4F3C-8B67-68CBB20D94A7Q40570435-9BF62FED-647F-4098-9CF5-74DF6B198458Q40605836-A83B8C94-B447-473C-AC62-FE5D168468A6Q40660035-F1D27BAE-15D8-46DA-BA74-75E302A00BEDQ40719049-A40453C4-169E-4FF2-89E9-83B6F8DF991CQ40968227-D1A1F326-C5F7-4BDB-A050-4A88BF23DFFCQ41503949-197AAF18-B1C8-413A-ACE2-B03351BF6F16Q41599125-933FE8F1-4C4A-4E27-9DAC-F9B73CCA341D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier Peman
@ast
Javier Peman
@en
Javier Peman
@es
Javier Peman
@nl
Javier Peman
@sl
type
label
Javier Peman
@ast
Javier Peman
@en
Javier Peman
@es
Javier Peman
@nl
Javier Peman
@sl
prefLabel
Javier Peman
@ast
Javier Peman
@en
Javier Peman
@es
Javier Peman
@nl
Javier Peman
@sl
P106
P1153
7003468500
P21
P31
P496
0000-0003-3222-5653